Review



nbp1 77206af700  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Novus Biologicals nbp1 77206af700
    Nbp1 77206af700, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp1+77206af700/APOBEC3G+Antibody+%5BAlexa+Fluor%C2%AE+700%5D/pmc13043299-377-67-63
    Average 94 stars, based on 2 article reviews
    nbp1 77206af700 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Staining:

    Article Title: TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size
    Article Snippet: .. The staining panel comprised Live/dead BV510, Life Technologies cat. no. L34957 ; CD4 BV605, BioLegend cat. no. 317438, Clone OKT4; CD8 BUV737, BD cat. no. 564629, Clone SK1; CD45RA BV650, BioLegend cat. no. 304136, Clone HI100; CD27 BUV496, BD cat. no. 751678, Clone O323; CCR7 BUV563, BD cat. no. 741317, Clone 3D12; IFIT1 APC, Novus Biologicals cat. no. NBP2-71005APC, Clone OTI3G8; APOBEC3G AF700, Novus Biologicals cat. no. NBP1-77206AF700, polyclonal; pSTAT1 (p701) AF488, BD cat. no. AB_2737715, Clone 4a; pSMAD2(pS465/pS467)/pSMAD3 (pS423/pS425) PE-CF594, BD cat. no. 562697, Clone O72-670; p24 RD1, Beckman Coulter cat. no. 6604667, Clone KC57; PD-1 BV711, BD cat. no. 564017, Clone EH12.1; and BCL-2 BUV395, cat. no. custom, Clone Bcl-2/100. ..

    Article Title: TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size.
    Article Snippet: Staining for HIV-1 p24 was performed on day 4 post-infection using BD Phosflow Fix Buffer I (BD) and BD Phosflow Perm Buffer III (BD) according to the manufacturer’s instructions. .. The staining panel comprised Live/dead BV510, Life Technologies cat. no. L34957; CD3 BUV615, BD cat. no. 612992, Clone UCHT1; CD4 BV605, BioLegend cat. no. 317438, Clone OKT4; CD8 BUV737, BD cat. no. 564629, Clone SK1; CD45RA BV650, BioLegend cat. no. 304136, Clone HI100; CD27 APC-eFluor 780, eBioscience cat. no. 47027942, Clone O323; CCR7 BUV563, BD cat. no. 741317, Clone 3D12; MX2 AF488, Santa Cruz Biotechnology cat. no. 271527, Clone H-7; IFIT1 APC, Novus Biologicals cat. no. NBP2-71005APC, Clone OTI3G8; APOBEC3G AF700, Novus Biologicals cat. no. NBP1-77206AF700, polyclonal; pSTAT1 (p701) PE-CF594, BD cat. no. AB_2737715, Clone 4a; pIRF3 (pSer396) PerCP, Bioss cat. no. bs-3195R-PerCP, polyclonal; pIRF7 (pSer471+pSer472) AF350, Bioss cat. no. bs-3196R-A350, polyclonal; HIV-1 core antigen FITC, Beckman Coulter cat. no. 6604665, Clone KC57 and CTV BV421, Thermo Fisher Scientific cat. no. C34571. ..

    Article Title: Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy.
    Article Snippet: .. The staining panel included: LIVE/DEAD BV510, Life Technologies, L34957; CD3 BUV615, BD Biosciences, 612992, clone UCHT1; CD4 BV605, BioLegend, 317438, clone OKT4; CD45RA BV650, BioLegend, 304136, clone HI100; CD27 AF647, BD Biosciences, 567026, clone O323; CCR7 BUV563, BD Biosciences, 741317, clone 3D12; pIRF3 PerCP, Novus Biologicals, BS-3195R-PERCP, clone polyclonal; pIRF7 BUV496, BD Bioscience, custom, clone K47-671; pSTAT1 (p701) AF488, BD Biosciences, AB_2737715, clone 4a; IFIT1 APC, Novus Biologicals, NBP2-71005APC, clone OTI3G8; APOBEC3G AF700, Novus Biologicals, NBP1-77206AF700, clone polyclonal; and p24 RD1, Beckman Coulter, 6604667, clone KC57. ..

    Article Title: Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy
    Article Snippet: .. The staining panel included: LIVE/DEAD BV510, Life Technologies, L34957 ; CD3 BUV615, BD Biosciences, 612992, clone UCHT1; CD4 BV605, BioLegend, 317438, clone OKT4; CD45RA BV650, BioLegend, 304136, clone HI100; CD27 AF647, BD Biosciences, 567026, clone O323; CCR7 BUV563, BD Biosciences, 741317, clone 3D12; pIRF3 PerCP, Novus Biologicals, BS-3195R-PERCP, clone polyclonal; pIRF7 BUV496, BD Bioscience, custom, clone K47-671; pSTAT1 (p701) AF488, BD Biosciences, AB_2737715, clone 4a; IFIT1 APC, Novus Biologicals, NBP2-71005APC, clone OTI3G8; APOBEC3G AF700, Novus Biologicals, NBP1-77206AF700, clone polyclonal; and p24 RD1, Beckman Coulter, 6604667, clone KC57. ..

    Article Title: TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size
    Article Snippet: Staining for HIV-1 p24 was performed on day 4 post-infection using BD Phosflow Fix Buffer I (BD) and BD Phosflow Perm Buffer III (BD) according to the manufacturer’s instructions. .. The staining panel comprised Live/dead BV510, Life Technologies cat. no. L34957 ; CD3 BUV615, BD cat. no. 612992, Clone UCHT1; CD4 BV605, BioLegend cat. no. 317438, Clone OKT4; CD8 BUV737, BD cat. no. 564629, Clone SK1; CD45RA BV650, BioLegend cat. no. 304136, Clone HI100; CD27 APC-eFluor 780, eBioscience cat. no. 47027942, Clone O323; CCR7 BUV563, BD cat. no. 741317, Clone 3D12; MX2 AF488, Santa Cruz Biotechnology cat. no. 271527, Clone H-7; IFIT1 APC, Novus Biologicals cat. no. NBP2-71005APC, Clone OTI3G8; APOBEC3G AF700, Novus Biologicals cat. no. NBP1-77206AF700, polyclonal; pSTAT1 (p701) PE-CF594, BD cat. no. AB_2737715, Clone 4a; pIRF3 (pSer396) PerCP, Bioss cat. no. bs-3195R-PerCP, polyclonal; pIRF7 (pSer471+pSer472) AF350, Bioss cat. no. bs-3196R-A350, polyclonal; HIV-1 core antigen FITC, Beckman Coulter cat. no. 6604665, Clone KC57 and CTV BV421, Thermo Fisher Scientific cat. no. C34571 . ..

    Article Title: TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size.
    Article Snippet: .. The staining panel comprised Live/dead BV510, Life Technologies cat. no. L34957; CD4 BV605, BioLegend cat. no. 317438, Clone OKT4; CD8 BUV737, BD cat. no. 564629, Clone SK1; CD45RA BV650, BioLegend cat. no. 304136, Clone HI100; CD27 BUV496, BD cat. no. 751678, Clone O323; CCR7 BUV563, BD cat. no. 741317, Clone 3D12; IFIT1 APC, Novus Biologicals cat. no. NBP2-71005APC, Clone OTI3G8; APOBEC3G AF700, Novus Biologicals cat. no. NBP1-77206AF700, polyclonal; pSTAT1 (p701) AF488, BD cat. no. AB_2737715, Clone 4a; pSMAD2(pS465/pS467)/pSMAD3 (pS423/pS425) PE-CF594, BD cat. no. 562697, Clone O72-670; p24 RD1, Beckman Coulter cat. no. 6604667, Clone KC57; PD-1 BV711, BD cat. no. 564017, Clone EH12.1; and BCL-2 BUV395, cat. no. custom, Clone Bcl-2/100. ..



    Similar Products

    nbp1 77206af700  (Novus Biologicals)
    94
    Novus Biologicals nbp1 77206af700
    Nbp1 77206af700, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp1+77206af700/APOBEC3G+Antibody+%5BAlexa+Fluor%C2%AE+700%5D/pmc13043299-377-67-63
    Average 94 stars, based on 1 article reviews
    nbp1 77206af700 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    apobec3g af700  (Novus Biologicals)
    94
    Novus Biologicals apobec3g af700
    a , Ridge regression model weights of features associated with anti-PD-1 therapy at baseline (C01D01) and 24 hours after therapy (C01D02) that correlated with frequencies of HIV DNA-containing cells at EOT. b , Correlation between predicted and actual HIV DNA levels per million CD4 + T cells based on the ridge model ( ρ = 0.59, P = 0.035). c , Model illustrating cell-subset-specific ISG expression. The left heatmap shows ISG expression across monocyte, CD4 + and CD8 + T cell subclusters (red, high; gray, low). The middle bar plots display the relative ( z -scaled) fold change in gene expression at C01D02 versus C01D01 (values >0 indicate upregulation). The right heatmap shows expression of monocyte-specific and T-cell-specific ISGs at EOT in group 1 versus group 2 participants, normalized per gene (row z -score; red, increased expression; blue, decreased expression). Bar plots above indicate total HIV DNA levels per participant at EOT. d , In vitro stimulation assay. Memory CD4 + T cells and CD8-depleted PBMCs from five donors ( n = 5) were cultured with or without innate immune stimuli (IFNα, IFNγ, poly I:C or R848). Mean fluorescence intensity (MFI) of the antiviral proteins <t>APOBEC3G</t> and IFIT1 in memory CD4 + T cells was quantified by flow cytometry. Each point represents a biological replicate (donor); bars denote the mean ± s.e.m. Comparisons between memory CD4 + -only cultures and CD8-depleted PBMC co-cultures for each condition were performed using paired t -tests. e , f , In vitro HIV challenge assay. Memory CD4 + T cells and CD8-depleted PBMCs from five donors ( n = 5) were infected with HIV in the presence or absence of IFN agonists or signaling inhibitors. e , Representative flow cytometry plots show p24 + cells after 4 days of infection. f , Frequencies of p24 + cells (of total CD3 + T cells) were quantified per donor under each stimulation condition. Treatment with IFNα, IFNγ, poly I:C or R848 reduced infection, whereas blockade of IFN signaling (using a combination of antibodies against the IFNα/β receptor chain (IFNARi) and IFNγ) increased infection frequency. Comparisons among stimulation conditions (control, IFNα, IFNγ, poly I:C and R848) were analyzed by Friedman’s test followed by Dunn’s post hoc test. All bar and scatter plots display mean ± s.e.m. Unless otherwise indicated, all statistical tests were two-sided, with multiple comparison adjustments applied where specified; otherwise, exact nominal P values are reported in the figures. FMO, fluorescence minus one; Unstim, unstimulated.
    Apobec3g Af700, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nbp1+77206af700/APOBEC3G+Antibody+%5BAlexa+Fluor%C2%AE+700%5D/pmc12920136-406-72-74
    Average 94 stars, based on 1 article reviews
    apobec3g af700 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    a , Ridge regression model weights of features associated with anti-PD-1 therapy at baseline (C01D01) and 24 hours after therapy (C01D02) that correlated with frequencies of HIV DNA-containing cells at EOT. b , Correlation between predicted and actual HIV DNA levels per million CD4 + T cells based on the ridge model ( ρ = 0.59, P = 0.035). c , Model illustrating cell-subset-specific ISG expression. The left heatmap shows ISG expression across monocyte, CD4 + and CD8 + T cell subclusters (red, high; gray, low). The middle bar plots display the relative ( z -scaled) fold change in gene expression at C01D02 versus C01D01 (values >0 indicate upregulation). The right heatmap shows expression of monocyte-specific and T-cell-specific ISGs at EOT in group 1 versus group 2 participants, normalized per gene (row z -score; red, increased expression; blue, decreased expression). Bar plots above indicate total HIV DNA levels per participant at EOT. d , In vitro stimulation assay. Memory CD4 + T cells and CD8-depleted PBMCs from five donors ( n = 5) were cultured with or without innate immune stimuli (IFNα, IFNγ, poly I:C or R848). Mean fluorescence intensity (MFI) of the antiviral proteins APOBEC3G and IFIT1 in memory CD4 + T cells was quantified by flow cytometry. Each point represents a biological replicate (donor); bars denote the mean ± s.e.m. Comparisons between memory CD4 + -only cultures and CD8-depleted PBMC co-cultures for each condition were performed using paired t -tests. e , f , In vitro HIV challenge assay. Memory CD4 + T cells and CD8-depleted PBMCs from five donors ( n = 5) were infected with HIV in the presence or absence of IFN agonists or signaling inhibitors. e , Representative flow cytometry plots show p24 + cells after 4 days of infection. f , Frequencies of p24 + cells (of total CD3 + T cells) were quantified per donor under each stimulation condition. Treatment with IFNα, IFNγ, poly I:C or R848 reduced infection, whereas blockade of IFN signaling (using a combination of antibodies against the IFNα/β receptor chain (IFNARi) and IFNγ) increased infection frequency. Comparisons among stimulation conditions (control, IFNα, IFNγ, poly I:C and R848) were analyzed by Friedman’s test followed by Dunn’s post hoc test. All bar and scatter plots display mean ± s.e.m. Unless otherwise indicated, all statistical tests were two-sided, with multiple comparison adjustments applied where specified; otherwise, exact nominal P values are reported in the figures. FMO, fluorescence minus one; Unstim, unstimulated.

    Journal: Nature Medicine

    Article Title: Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy

    doi: 10.1038/s41591-025-04139-y

    Figure Lengend Snippet: a , Ridge regression model weights of features associated with anti-PD-1 therapy at baseline (C01D01) and 24 hours after therapy (C01D02) that correlated with frequencies of HIV DNA-containing cells at EOT. b , Correlation between predicted and actual HIV DNA levels per million CD4 + T cells based on the ridge model ( ρ = 0.59, P = 0.035). c , Model illustrating cell-subset-specific ISG expression. The left heatmap shows ISG expression across monocyte, CD4 + and CD8 + T cell subclusters (red, high; gray, low). The middle bar plots display the relative ( z -scaled) fold change in gene expression at C01D02 versus C01D01 (values >0 indicate upregulation). The right heatmap shows expression of monocyte-specific and T-cell-specific ISGs at EOT in group 1 versus group 2 participants, normalized per gene (row z -score; red, increased expression; blue, decreased expression). Bar plots above indicate total HIV DNA levels per participant at EOT. d , In vitro stimulation assay. Memory CD4 + T cells and CD8-depleted PBMCs from five donors ( n = 5) were cultured with or without innate immune stimuli (IFNα, IFNγ, poly I:C or R848). Mean fluorescence intensity (MFI) of the antiviral proteins APOBEC3G and IFIT1 in memory CD4 + T cells was quantified by flow cytometry. Each point represents a biological replicate (donor); bars denote the mean ± s.e.m. Comparisons between memory CD4 + -only cultures and CD8-depleted PBMC co-cultures for each condition were performed using paired t -tests. e , f , In vitro HIV challenge assay. Memory CD4 + T cells and CD8-depleted PBMCs from five donors ( n = 5) were infected with HIV in the presence or absence of IFN agonists or signaling inhibitors. e , Representative flow cytometry plots show p24 + cells after 4 days of infection. f , Frequencies of p24 + cells (of total CD3 + T cells) were quantified per donor under each stimulation condition. Treatment with IFNα, IFNγ, poly I:C or R848 reduced infection, whereas blockade of IFN signaling (using a combination of antibodies against the IFNα/β receptor chain (IFNARi) and IFNγ) increased infection frequency. Comparisons among stimulation conditions (control, IFNα, IFNγ, poly I:C and R848) were analyzed by Friedman’s test followed by Dunn’s post hoc test. All bar and scatter plots display mean ± s.e.m. Unless otherwise indicated, all statistical tests were two-sided, with multiple comparison adjustments applied where specified; otherwise, exact nominal P values are reported in the figures. FMO, fluorescence minus one; Unstim, unstimulated.

    Article Snippet: The staining panel included: LIVE/DEAD BV510, Life Technologies, L34957 ; CD3 BUV615, BD Biosciences, 612992, clone UCHT1; CD4 BV605, BioLegend, 317438, clone OKT4; CD45RA BV650, BioLegend, 304136, clone HI100; CD27 AF647, BD Biosciences, 567026, clone O323; CCR7 BUV563, BD Biosciences, 741317, clone 3D12; pIRF3 PerCP, Novus Biologicals, BS-3195R-PERCP, clone polyclonal; pIRF7 BUV496, BD Bioscience, custom, clone K47-671; pSTAT1 (p701) AF488, BD Biosciences, AB_2737715, clone 4a; IFIT1 APC, Novus Biologicals, NBP2-71005APC, clone OTI3G8; APOBEC3G AF700, Novus Biologicals, NBP1-77206AF700, clone polyclonal; and p24 RD1, Beckman Coulter, 6604667, clone KC57.

    Techniques: Expressing, Gene Expression, In Vitro, Cell Culture, Fluorescence, Flow Cytometry, Infection, Control, Comparison